A sampling of media coverage that profiles or mentions CCRM
Using iPSCs as starting material for advanced therapies. Genetic Engineering and Biotechnology News, June 4, 2024.
Coming to life at McMaster University. Hamilton City Magazine, June 3, 2024.
“Conducting research at universities is becoming more and more like working at a research hotel.” Life Science Sweden, May 23, 2024.
Delegation from Victoria, Australia participating in Bio Korea 2024 introduces life science ecosystem. NewsPim, May 9, 2024. (Original is written in Korean; view an English translation here.)
New Modality Support is implemented for commercialization of research from OligoNova and CCRM Nordic. University of Gothenburg Akademiliv, May 8, 2024. (Original is written in Swedish; view an English translation here.)
Not-for-profit models needed for commercially unviable rare disease drugs. Pink Sheet – Citeline Regulatory, May 3, 2024.
OmniaBio’s impact and future with Mitchel Sivilotti. Canadian SME, April 27, 2024.
The Power List 2024. The Medicine Maker, April 10, 2024.
Two new gene therapies could present possible cure for sickle cell disease, but access is an obstacle. The Globe and Mail, March 13, 2024.
New cell and gene therapy training laboratory opens at OVC. Ontario Veterinary College, February 21, 2024.
NGen reveals $86.7M in advanced manufacturing projects at the N3 summit. Canadian Manufacturing, February 9, 2024.
Construction of GoCo Active Lab has begun. Nordic Life Science News, January 26, 2024.
Gene therapy revolutionizing hemophilia treatment, unlocking new research opportunities. Healthing, January 25, 2024.
Will AI expertise push Canada forward as a biopharma hub? In Vivo, January 22, 2024. (Subscription required to view this article.)
Life Sciences Ontario announces recipients of 2024 LSO Awards. National Post, January 15, 2024.
BMC names their new Board of Directors. Canadian Manufacturing, January 12, 2024.
Canada’s biomedical brain drain is reversing. Let’s continue that trend. The Hill Times, January 8, 2024.
